To investigate the role of aldosterone in the upregulation of Fgf23 secretion after TAC, we orally treated WT animals with the mineralocorticoid receptor inhibitor spironolactone over 2 weeks post-TAC. Here, NR3C2 is linked to persistent truncus arteriosus.